We're fortunate to have a star neurosurgical couple in our Department. Dr. Gavin Dunn @GavinPDunn, Director of Immunotherapy, and Dr. Pamela Jones, Director of Pituitary Surgery and Associate Residency Program Director are shown here at the celebration of the naming for Dr. Dunn as an MGH Research Scholar. MGH Research Scholars are given 5 years of unrestricted funding to pursue novel creative scientific ideas, a singular recognition of scientific excellence @MGH_RI! Drs Jones and Dunn are two outstanding surgeons in our neurosurgical oncology practice @MGHNeurosurg!
Moderna and @Merck announce that that the Phase 2b KEYNOTE-942/mRNA-4157-P201 trial of mRNA-4157/V940, an investigational personalized #mRNA#cancer#vaccine, in combination with KEYTRUDA®, Merck’s anti-PD-1 therapy, demonstrated a statistically significant and clinically..(1/2)
Our new story is just our today, in which we show that meningeal lymphatics dysfunction modulates the sex difference in the stress susceptibility to depression- and anxiety-like behaviors in mice: https://t.co/V71JfurHD5
A library of mutant p53–reactive TCRs has been established. Learn how this library can be used in the treatment of patients with cancer in this article by Kim, Rosenberg, et al.
https://t.co/SwJ7AZBSuI
@tellkrish @franklowery@Noam_Levin_@slgoff_SB@AParikhMD#CIRReviewerStar
Happy to share our newest publication in @NatImmunol
Congratulations to all authors, so proud to be your colleague. Full manuscript available here https://t.co/kKbYuaK0J4
Fresh off the press, wonderful work of my student @MaoLi001 showing smell receptor role in breast cancer brain metastasis @MGH_RI @MGHNeuroSci@MGHNeurology
Journal club presentation on "#Glioblastoma Model Using #Human#Cerebral Organoids" by one of @TannousLab's members @schweani! Very exciting stuff but is this model better than the PDX mouse model? Read more about this in the journal @CellReports: https://t.co/nxhEz3kTQM #cancer